Hot take โ Building a B2B SaaS is 100x easier than building a B2C SaaS. Fight me.
Anonymous 1
Hey I am on Medialย โขย 2m
100x easier? Maybe 10x easier. B2B SaaS might have smaller customer bases, but convincing businesses to adopt your solution and integrating with their existing stack is no cakewalk
0 replies
More like this
Recommendations from Medial
Kritarth Mittal โข Soshals
Founder, Soshals | C...ย โขย 2m
Hot take โ Building a B2B SaaS is 100x easier than building a B2C SaaS. Fight me.
A SaaS-based trip planning tool that connects B2B travel companies, B2C local agencies, hotels/home stays, and drivers.
How It Works:
B2C agents receive inquiries from customers and add them to the platform.
B2B agencies can submit quotations, inc
See More
2 replies4 likes
Mehul Fanawala
ย โขย
The Clueless Companyย โขย 9m
Did you know?
70% of SaaS sales come from EXISTING customers, not new ones.
So while you're chasing new leads, don't forget:
1.โ โ Deliver VALUE consistently: Happy customers become loyal customers.
2.โ โ Leverage feedback: Improve your product bas
Dhibot AI โ AI Revolution for Industrial, Financial & Automation Sectors
๐ An AI-Powered SaaS Solution for Multi-Industry Applications
๐น Executive Summary
Dhibot AI is an AI-Powered SaaS Platform that provides AI-Driven Automation Solutions in se
hey devs
i am a kid who is new in tech, help me explore this world
what are different types of software/tools
which are in demand ?
i heard about a few
- ecommerce apps, social media apps
- online tools like code editors/ pdf converters/image resi
See More
4 replies8 likes
Asifur Borbhuyan
๐ฟย โขย 9m
Bengaluru-based revenue automation startup MeetRecord has raised $2.7 million in a pre-series A funding round.
The round was led by the Singapore-based venture capital fund SWC Global, with significant participation from existing investor All In Ca
See More
2 replies5 likes
Aditya Tiwari
Founder of Native Kn...ย โขย 4m
Building Patholite for Small Labs โ Do These Features Solve Real Problems?
Patholite is a lab management solution designed to make operations easier and more affordable for small and medium-sized pathology labs.
Problem:
1. High Costs: Current lab
One important thing to consider for B2C founders: Ask when will people use my product. The cost to creation is at an all time low thanks to AI, but people have enough products for their dopamine addiction.
Are users using your new AI driven metaver
๐๐ป๐ฑ๐ถ๐ฎ๐ป ๐๐ผ๐๐ป๐ฑ๐ฒ๐ฟ๐ ๐๐ฟ๐ฒ ๐ฆ๐น๐ฒ๐ฒ๐ฝ๐ถ๐ป๐ด ๐ผ๐ป ๐ฎ $๐ญ๐ฌ๐ ๐๐ ๐๐ผ๐น๐ฑ๐บ๐ถ๐ป๐ฒ
Right now, ๐ฌ๐จ๐ฅ๐จ ๐๐จ๐ฎ๐ง๐๐๐ซ๐ฌ in the US are launching AI startups.
They are scaling to $๐๐๐ ๐๐๐ ๐ข๐ง ๐ฆ๐จ๐ง๐ญ๐ก๐ฌ โwith teams of less than ๐๏ฟฝ
Forget VC Funding: Best Alternatives of VC funding
For decades, raising round after round, burning cash and the founders are left with one digit equity.
VCs own the equity. Founders are like puppets.
They want 10x returns in 5-7 years whether you